biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Is There a Case Against xB3?

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Jun 21, 2023 6:55pm

85 Views

Post# 35508113

RE:RE:RE:Is There a Case Against xB3?

Doesn't matter who they are directed at!

They don't care about your opinion and I sure wished I hadn't!
But that's water until the bridge now isn't it?

As for walking good for you.

Myself I use to do a 10k walk per day and never missed a day.

Then 3 years next month that went all to hell with a stroke.

None of that anymore but still consider myself lucky because I still lead a pretty normal life.

So for you and all the old guys here you just never know!

So enjoy as much as you can when you can.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market